This resource provides practical articles on Cost Management Strategies and links to locate them. These articles are provided to assist pharmacy managers and directors in dealing with the management issues focused on the affordability and accessibility of pharmaceuticals. Current topics covered in this new resource section include pharmacists' intervention strategies, formulary management strategies, population-based strategies, and anti-infective management strategies. Additional strategies will be added periodically to assist managers and directors in managing high-cost issues in pharmacy.

Note: This icon represents that access is limited to ASHP members only. To view a file, you will be asked to enter your ASHP User ID and password.

1. Arnold FW, McDonald LC, Newman D, Smith RS, Ramirez JA. Improving antimicrobial use: Longitudinal assessment of an antimicrobial team including a clinical pharmacist. J Manage Care Pharm. 2004 Mar-Apr;10(2): 152-8.
2. Purcell K, Fergie J. Effect of an educational program on the treatment of RSV lower-respiratory-tract infection. Am J Health Syst Pharm. 2003; 60: 759-67.
3. Kuti JL, Le TN, Nightingale DP, Nicolau DP, Quintiliani R. Pharmacoeconomics of a pharmacist-managed program for automatically converting levofloxacin route from i.v. to oral. Am J Health Syst Pharm. 2002; 59: 2209-15.
4. Goldwater SH, Milkovich G, Morrison AJ, Lindgren B. Comparison of therapeutic interchange with standard educational tools for influencing fluoroquinolone prescribing. Am J Health Syst Pharm. 2001; 58: 1740-45.
5. Gross R, Morgan AS, Kinky DE, Weiner M, Gibson GA, Fishman NO. Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin Infect Dis. 2001 Aug 1;33(3):289-95.
6. Wong-Beringer A, Nguyen KH, Razeg J. Implementing a program for switching from i.v. to oral antimicrobial therapy. Am J Health Syst Pharm. 2001; 58:1146-49.
7. Lomaestro B. Therapeutic interchange of fluoroquinolones at a medical center. Am J Health Syst Pharm. 2001; 58: 904-907.
8. Gora-Harper ML, Rapp RL, Finney JP. Development of a best-practice model at a university hospital to increase efficiency in the management of patients with community-acquired pneumonia. Am J Health Syst Pharm. 2000; 57(Suppl 3): S6-9.
9. Paladino JA. Economic justification of antimicrobial management programs: Implications of antimicrobial resistance. Am J Health Syst Pharm. 2000; 57(Suppl 2): S10-12.
10. Halpern M, Schmier J, Richner R, Togias A. Antimicrobial treatment patterns, resource utilization, and charges associated with acute sinusitis in asthma patients. Am J Health Syst Pharm. 2000; 57: 875-81.
11. Gums JG, Yancey RW, Hamilton CA, Kubilis PS. A randomized, prospective study measuring outcomes after antibiotic therapy intervention by a multidisciplinary consult team. Pharmacotherapy. 1999 Dec;19(12): 1369-77.
12. Jozefiak ET, Lewicki JE, Kozinn WP. Compter-assisted antimicrobial surveillance in a community teaching hospital. Am J Health Syst Pharm. 1995 Jul 15;52(14): 1536-40.
13. Okpara AU, Maswoswe JJ, Stewart K. Criteria-based antimicrobial IV to oral conversion program. Formulary. June 1995; 30(6): 343-48.